About this trial
Constitution of a biobank of tissues, whole blood and plasma samples and stools to identify markers associated with treatment response, postoperative morbidity including neuro-cognitive and mood complications and prognosis of Inflammatory Bowel disease or colorectal cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ulcerative colitis, Crohn's disease or colorectal disease
Digestive resection with useless tissue available
Information consent signed
Disqualifiers
None
Trial population
Patients older than 18 years-old. With an Ulcerative colitis, Crohn's Disease or colorectal cancer Operated in the Departement of digestive surgery of Saint-Antoine Hospital After signature of the information consent
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Relation between biological parameters and outcomes of digestive disease (IBD, CRC)
identify relations between serumon response to treatment, postoperative outcomes including neuro-cognitive and mood complications and prognosis.
Secondary outcomes
Relation between biological parameters and outcomes of digestive disease (IBD, CRC)
identify relations between plasma on response to treatment, postoperative outcomes including neuro-cognitive and mood complications and prognosis.
Relation between biological parameters and outcomes of digestive disease (IBD, CRC)
identify relations between DNA on response to treatment, postoperative outcomes including neuro-cognitive and mood complications and prognosis.
Relation between biological parameters and outcomes of digestive disease (IBD, CRC)
identify relations between faeces) on response to treatment, postoperative outcomes including neuro-cognitive and mood complications and prognosis.
Exploratory study on the physiopathology of host-microbiota interactions to determinate the occurrence of intestinal and extra-intestinal complications
genetic polymorphisms, serum markers, intestinal microbiota markers to determining the occurrence of intestinal and extra-intestinal complications
Sponsors and contacts
Click on the lead sponsor to view all of their trials.